HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Felicia Cosman Selected Research

Teriparatide (Parathar)

11/2020Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.
1/2020Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial.
8/2016Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
7/2015Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate.
1/2014Combination therapy for osteoporosis: a reappraisal.
6/2013Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene.
6/2012Changes in vitamin D metabolites during teriparatide treatment.
3/2011Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
1/2010Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women.
10/2009Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Felicia Cosman Research Topics

Disease

59Osteoporosis
01/2022 - 03/2003
10Postmenopausal Osteoporosis
01/2021 - 03/2007
10Bone Resorption
01/2018 - 08/2005
5Osteoporotic Fractures
01/2022 - 03/2013
4Hip Fractures (Intertrochanteric Fractures)
01/2021 - 07/2009
3Osteoarthritis
01/2022 - 01/2016
3Femoral Fractures (Femoral Fracture)
10/2016 - 11/2010
2Hypercalcemia (Milk Alkali Syndrome)
08/2016 - 11/2014
2Wounds and Injuries (Trauma)
10/2012 - 07/2009
1Infections
01/2022
1Neoplasms (Cancer)
01/2022
1Heart Failure
11/2020
1Hip Osteoarthritis (Coxarthrosis)
01/2020
1Osteonecrosis (Kienbock's Disease)
10/2016
1Feeding and Eating Disorders (Eating Disorder)
03/2016
1Weight Loss (Weight Reduction)
03/2016
1Hypertension (High Blood Pressure)
03/2013
1Pain (Aches)
11/2010
1Chronic Disease (Chronic Diseases)
12/2007
1Secondary Hyperparathyroidism
12/2007
1Vitamin D Deficiency
12/2007
1Menstruation Disturbances
08/2007
1Oligomenorrhea
08/2007
1Amenorrhea
08/2007
1Atrial Fibrillation
05/2007
1Congenital Abnormalities (Deformity)
08/2005
1Prolapse
07/2003
1Pelvic Organ Prolapse
07/2003
1Venous Thromboembolism
05/2003
1Hot Flashes
05/2003
1Breast Neoplasms (Breast Cancer)
05/2003
1Uterine Diseases (Endometrial Disease)
05/2003

Drug/Important Bio-Agent (IBA)

14Alendronate (Alendronate Sodium)FDA LinkGeneric
11/2021 - 08/2005
14Teriparatide (Parathar)FDA Link
11/2020 - 03/2004
12Diphosphonates (Bisphosphonates)IBA
01/2021 - 05/2003
10Parathyroid Hormone (Parathormone)IBA
07/2020 - 03/2003
10Zoledronic Acid (Zometa)FDA Link
05/2015 - 05/2007
9abaloparatideIBA
11/2020 - 08/2016
8Bone Density Conservation AgentsIBA
01/2021 - 12/2005
7DenosumabFDA Link
01/2022 - 12/2014
6romosozumabIBA
11/2021 - 10/2016
6MineralsIBA
07/2020 - 08/2007
5CalciumIBA
03/2016 - 05/2005
5Raloxifene Hydrochloride (Evista)FDA Link
06/2013 - 05/2003
5Pharmaceutical PreparationsIBA
03/2013 - 07/2003
4Collagen Type I (Type I Collagen)IBA
11/2014 - 04/2009
3Peptides (Polypeptides)IBA
11/2014 - 12/2005
3collagen type I trimeric cross-linked peptideIBA
11/2014 - 04/2009
3Vitamin DFDA LinkGeneric
06/2012 - 05/2005
2Monoclonal AntibodiesIBA
01/2022 - 10/2016
2Anabolic AgentsIBA
01/2021 - 12/2008
2Tetracycline (Achromycin)FDA LinkGeneric
01/2020 - 04/2007
2Oral ContraceptivesIBA
03/2016 - 08/2007
2Biomarkers (Surrogate Marker)IBA
11/2014 - 05/2012
2hydroxide ionIBA
06/2012 - 12/2007
2Estrogens (Estrogen)FDA Link
04/2012 - 05/2003
2GlucocorticoidsIBA
11/2010 - 12/2008
2Ibandronic Acid (Boniva)FDA Link
04/2009 - 06/2007
2TamoxifenFDA LinkGeneric
07/2003 - 05/2003
1Cathepsin KIBA
01/2021
1odanacatibIBA
01/2021
1Parathyroid Hormone-Related ProteinIBA
11/2020
1omega-Chloroacetophenone (Mace)IBA
11/2020
1N,N-dimethyl-4-anisidine (DMPA)IBA
03/2016
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
03/2016
1ProcollagenIBA
11/2014
1Alkaline PhosphataseIBA
11/2014
1Calcium-Sensing ReceptorsIBA
11/2014
1JTT 305IBA
11/2014
1N 30IBA
10/2012
125-hydroxyvitamin DIBA
06/2012
11,25-dihydroxyvitamin DIBA
06/2012
1CollagenIBA
03/2012
1Proton Pump InhibitorsIBA
11/2010
1NitrogenIBA
06/2007
1Conjugated (USP) Estrogens (Premarin)FDA Link
07/2003
1Selective Estrogen Receptor Modulators (SERM)IBA
05/2003

Therapy/Procedure

29Therapeutics
01/2022 - 08/2005
5Duration of Therapy
01/2020 - 03/2004
4Hip Replacement Arthroplasty (Total Hip Replacement)
01/2022 - 01/2016
2Fracture Fixation
01/2018 - 09/2009
1Transdermal Patch
01/2010
1Injections
01/2010
1Retreatment
06/2009
1Aftercare (After-Treatment)
03/2003